• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

How Ozempic Maker Novo Nordisk Lost Its Shine

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.

Eshe Nelson
Author: Eshe Nelson

Written by

Eshe Nelson

in

Appointments and Executive Changes, Company Reports, Drugs (Pharmaceuticals), GLP-1 RAs (Drug), Ozempic (Drug), Regulation and Deregulation of Industry, Stocks and Bonds
←‘Fleetwood Mac’ at 50: A Marvel of Serendipity and Perfectionism
Cannonball with Wesley Morris: Beyoncé Isn’t Giving Up on America→

More posts

  • Rihanna’s Beverly Hills home hit by gunfire; suspect arrested, LAPD says

  • Alexander brothers found guilty on all counts in sex trafficking trial

  • Fashionable Wall Street Bros Set Off a Social Media Storm

  • Casey Wasserman’s name dropped from agency following Ghislaine Maxwell scandal

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube